神经科指南

订阅

MedSci主页 / 所有栏目 / 神经科指南

2020 循证指南：儿童和青少年格林-巴利综合征的诊断和治疗

2020-01-07 国外神经内科相关专家小组（统称） Eur J Paediatr Neurol. 2020 Jan 7.

格林-巴利综合征

本文是有相关专业协会组织制定的关于儿童和青少年格林-巴利综合征的诊断和治疗循证指南。主要针对儿童和青少年格林-巴利综合征的诊断和治疗的相关内容提出指导建议。 、

中文标题：

2020 循证指南：儿童和青少年格林-巴利综合征的诊断和治疗

英文标题：

Diagnosis and treatment of Guillain-Barré Syndrome in childhood and adolescence: An evidence- and consensus-based guideline.

发布机构：

国外神经内科相关专家小组（统称）

发布日期：

2020-01-07

简要介绍：

本文是有相关专业协会组织制定的关于儿童和青少年格林-巴利综合征的诊断和治疗循证指南。主要针对儿童和青少年格林-巴利综合征的诊断和治疗的相关内容提出指导建议。 、

 

拓展指南：与儿童相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2020 循证指南：儿童和青少年格林-巴利综合征的诊断和治疗)] GetToolGuiderByIdResponse(projectId=1, id=0815c1c001855ee7, title=2020 循证指南：儿童和青少年格林-巴利综合征的诊断和治疗, enTitle=Diagnosis and treatment of Guillain-Barré Syndrome in childhood and adolescence: An evidence- and consensus-based guideline., guiderFrom=Eur J Paediatr Neurol. 2020 Jan 7., authorId=null, author=, summary=本文是有相关专业协会组织制定的关于儿童和青少年格林-巴利综合征的诊断和治疗循证指南。主要针对儿童和青少年格林-巴利综合征的诊断和治疗的相关内容提出指导建议。 、 , cover=, journalId=null, articlesId=null, associationId=952, associationName=国外神经内科相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Tue Jan 07 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>本文是有相关专业协会组织制定的关于儿童和青少年格林-巴利综合征的诊断和治疗循证指南。主要针对儿童和青少年格林-巴利综合征的诊断和治疗的相关内容提出指导建议。 、</P> <P> </P>拓展指南：<strong>与<font color=red>儿童</font>相关指南：</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=15cfc1c001855120" title="2020 印度国家共识声明：儿童眼科检查、屈光和弱视的治疗" target=_blank>2020 印度国家共识声明：儿童眼科检查、屈光和弱视的治疗</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=55e7e1c001853369" title="中国儿童代谢健康型肥胖定义与筛查专家共识" target=_blank>中国儿童代谢健康型肥胖定义与筛查专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=139501c0018a69ef" title="2018 SIP指南：儿童急性中耳炎的管理（更新版）" target=_blank>2018 SIP指南：儿童急性中耳炎的管理（更新版）</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=97f5d1c0018a5246" title="NCCN临床实践指南：儿童侵袭性成熟B细胞淋巴瘤（2020.V1）" target=_blank>NCCN临床实践指南：儿童侵袭性成熟B细胞淋巴瘤（2020.V1）</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f8ae01c0018a45fd" title="2019 AASLD实践指南：成人和儿童自身免疫性肝炎的诊断和治疗" target=_blank>2019 AASLD实践指南：成人和儿童自身免疫性肝炎的诊断和治疗</a></li> 更多信息请点击：<a href="https://www.medsci.cn/guideline/list.do?q=%E5%84%BF%E7%AB%A5" target=_blank>有关儿童更多指南</a></ul>, tagList=[TagDto(tagId=5131, tagName=格林-巴利综合征)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4853, appHits=428, showAppHits=14, pcHits=2410, showPcHits=3297, likes=59, shares=15, comments=6, approvalStatus=1, publishedTime=Mon Jan 27 19:52:53 CST 2020, publishedTimeString=2020-01-07, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Jan 27 19:52:53 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 13:16:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 循证指南：儿童和青少年格林-巴利综合征的诊断和治疗)])
2020 循证指南：儿童和青少年格林-巴利综合征的诊断和治疗
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1188249, encodeId=a44311882496d, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88a5533768, createdName=ms3000001146087334, createdTime=Wed Jan 26 10:46:24 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069913, encodeId=edc1106991369, content=很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/26/7ed74b1ce699ba8f6f5f82d4db66f08e.jpg, createdBy=8ab32323230, createdName=12254586m05暂无昵称, createdTime=Sat Nov 13 16:28:50 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051587, encodeId=5679105158e4c, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6d25607216, createdName=ms3000001664914345, createdTime=Wed Sep 15 19:47:12 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965677, encodeId=c8ef9656e729, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388e5381768, createdName=ms7000001395190706, createdTime=Fri May 14 21:09:09 CST 2021, time=2021-05-14, status=1, ipAttribution=)]
    2022-01-26 ms3000001146087334

    有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1188249, encodeId=a44311882496d, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88a5533768, createdName=ms3000001146087334, createdTime=Wed Jan 26 10:46:24 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069913, encodeId=edc1106991369, content=很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/26/7ed74b1ce699ba8f6f5f82d4db66f08e.jpg, createdBy=8ab32323230, createdName=12254586m05暂无昵称, createdTime=Sat Nov 13 16:28:50 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051587, encodeId=5679105158e4c, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6d25607216, createdName=ms3000001664914345, createdTime=Wed Sep 15 19:47:12 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965677, encodeId=c8ef9656e729, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388e5381768, createdName=ms7000001395190706, createdTime=Fri May 14 21:09:09 CST 2021, time=2021-05-14, status=1, ipAttribution=)]
    2021-11-13 12254586m05暂无昵称

    很多

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1188249, encodeId=a44311882496d, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88a5533768, createdName=ms3000001146087334, createdTime=Wed Jan 26 10:46:24 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069913, encodeId=edc1106991369, content=很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/26/7ed74b1ce699ba8f6f5f82d4db66f08e.jpg, createdBy=8ab32323230, createdName=12254586m05暂无昵称, createdTime=Sat Nov 13 16:28:50 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051587, encodeId=5679105158e4c, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6d25607216, createdName=ms3000001664914345, createdTime=Wed Sep 15 19:47:12 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965677, encodeId=c8ef9656e729, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388e5381768, createdName=ms7000001395190706, createdTime=Fri May 14 21:09:09 CST 2021, time=2021-05-14, status=1, ipAttribution=)]
    2021-09-15 ms3000001664914345

    good

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1188249, encodeId=a44311882496d, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88a5533768, createdName=ms3000001146087334, createdTime=Wed Jan 26 10:46:24 CST 2022, time=2022-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069913, encodeId=edc1106991369, content=很多, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/26/7ed74b1ce699ba8f6f5f82d4db66f08e.jpg, createdBy=8ab32323230, createdName=12254586m05暂无昵称, createdTime=Sat Nov 13 16:28:50 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051587, encodeId=5679105158e4c, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6d25607216, createdName=ms3000001664914345, createdTime=Wed Sep 15 19:47:12 CST 2021, time=2021-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965677, encodeId=c8ef9656e729, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=388e5381768, createdName=ms7000001395190706, createdTime=Fri May 14 21:09:09 CST 2021, time=2021-05-14, status=1, ipAttribution=)]
    2021-05-14 ms7000001395190706

    棒

    0